Bibliography
- EFRAT S: Prospects for gene therapy of insulin- dependent diabetes mellitus. Diabetologia (1998) 41:1401–1409.
- LEIBOWITZ G, BEATTIE GM, KAFRI T et al.: Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes (1999) 48:745–753.
- •A comparison of viral vectors which may be important for gene transfer into pancreatic cells.
- FERBER S, BELTRANDELRIO H, JOHNSON JH et al.: GLUT-2 gene transfer into insulinoma cells confers both low and high affinity glucose-stimulated insulin release. Relationship to glucokinase activity. J. Biol. Chem. (1994) 269:11523–11529.
- MCCLENAGHAN NH, FLATT PR: Engineering cultured insulin-secreting pancreatic B-cell lines. J. Mol. Med. (1999) 77:235–243.
- SIMPSON AM, MARSHALL GM, TUCH BE et al.: Genetherapy of diabetes: glucose-stimulated insulin secretion in a human hepatoma cell line (HEP G2ins/g). Gene Ther. (1997) 4:1202–1215.
- SIMPSON AM, SZYMANSKA B, TUCH BE, MARSHALL GM:Secretion and storage of insulin from a human hepatoma cell line (1111117-INIS). Transplant. Proc. (1999) 31 :812.
- CLARK SA, QUAADE C, CONSTANDY H et al.: Novelinsulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression [published erratum appears in Diabetes. Diabetes (1997) 46:958–967.
- HOHMEIER HE, BELTRANDELRIO H, CLARK SA, HENKEL-RIEGER R, NORMINGTON K, NEWGARD CB: Regulation of insulin secretion from novel engineered insuli-noma cell lines. Diabetes (1997) 46:968–977.
- •Reviews the current knowledge about glucose-stimulated insulin secretion and the problems that have to be solved to use them in therapy for diabetes.
- MACFARLANE WM, CHAPMAN JC, SHEPHERD RM et al.: Engineering a glucose-responsive human insulin-secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinemic hypoglycemia of infancy. J. Biol. Chem. (1999) 274:34059–34066.
- •Novel use of islets derived from PHHI patients.
- JU Q, EDELSTEIN D, BRENDEL MD et al.: Transduction ofnon-dividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia (1998) 41:736–739.
- RABINOVITCH A, SUAREZ-PINZON W, STRYNADKA K etTransfection of human pancreatic islets with an anti-apoptotic gene (bc1-2) protects beta-cells from cytokine-induced destruction. Diabetes (1999) 48:1223–1229.
- GIANNOUKAKIS N, MI Z, GAMBOTTO A et al.: Infection of intact human islets by a lentiviral vector. Gene Ther. (1999) 6:1545–1551.
- GIANNOUKAKIS N, RUDERT WA, GHIVIZZANI Sc et al: Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-lbeta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes (1999) 48: 1730-1736.
- GALLICHAN WS, KAFRI T, KRAHL T, VERMA IM, SARVET-NICK N: Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum. Gene Ther. (1998) 9:2717–2726.
- •Example of efficient transduction of islet cells by lentiviral vectors.
- BEATTIE GM, CIRULLI V, LOPEZ AD, HAYEK A: Ex vivo expansion of human pancreatic endocrine cells. J. Endocrinol. Metab. (1997) 82:1852–1856.
- MURUVE DA, MANFRO RC, STROM TB, LIBERMANN TA: Ex vivo adenovirus-mediated gene delivery leads to long-term expression in pancreatic islet transplants. Transplantation (1997) 64:542–546.
- SCHMID RM, WEIDENBACH H, YAMAGUSHI H, LUHRS H, LIPTAY S, ADLER G: Direct gene transfer into the rat pancreas using DNA-liposomes. Eur. j Clin. Invest. (1998) 28:220–226.
- BARTLETT R, DENTS M, INVERARDI L, RICORDI C: Introduction of immunomodulatory genes into isolated pancreatic islets via biolistic particle bombardment. Transplant. Proc. (1998) 30:452.
- RODRIGUEZ RH, PALJUG WR, LAKEY JR, TAYLOR MJ, GRAYSON D: Biolistic bioengineering of pancreatic beta-cells with fluorescent green protein. Transplant. Proc. (1998) 30:465–468.